Member Info for M_Night

Can see a lot of ODX money coming here this afternoon and next week, considering we are derisked and have much better fundamentals and a solid pipeline taking form.

It's been the low 30s for months now and that's before the news we had. :)

Regardless, it's the mcap that matters here and for BRH the uplift screams 5-10x bagger once sold.

...It's a steal here and we're just waiting on them to sell the test or Paraytec. We know this company has no issue paying out substantial special dividends when they sell as asset off.

We have a next to finished and proven world leading COVID test, Sepsis test and Blood cancer test. With commercial partners in late stage discussion, many now 3rd as per the RNS and now likely 4th round and there are those sitting on the fence at 32p!

Always strange to me when people are happy to pay over 40p, but not buy in at the floor.

It's

Although the top is a buy!

09-Dec-21 12:52:30 8.75 1,750,000 Unknown* 8.50 8.75 153.13k
09-Dec-21 13:30:58 8.625 1,500,000 Unknown* 8.50 8.75 129.38k O
09-Dec-21 13:30:58 8.625 1,500,000 Unknown* 8.50 8.75 129.38k

33.79 all buys, not sells.

Yup. It also only took GDR 1.5 weeks to get the CE mark from submission. Nov 29th to Dec 8th.

Agreement to be reached by the end of this year / early next with a commercial partner. Couple that with submission for the CE mark and 100p+ will happen in a flash.

If you read into the RNS, seems quite clear potential buyers and commercial partners are keen to reach an agreement soon.

The RNS states the test itself will undergo a study early in the new year (aka Jan), but that's not related to reaching a deal.

I believe they are going to announce this very soon, given that they are far in with third round discussions.

33p has been paid!

Test results in 5mins from sample and doesn't require a lab.

Highly sensitive and can also detect pre-symptomatic. Highly accurate.

Can detect in-tact virus.

Cheap to produce and portable. Just £1,500 for a machine and £2 for a testing cartridge.

This will be one of the best tests available for medical places, such as GPs, hospitals. Airports and other events.

Honestly, this is a 5-10x bagger here, because even that's only a 100-200mil mcap for BRH.....

Sepsis and Bladder Cancer tests even bigger game changers + other investments.

RNS couldn't be more clear. They are in late stage / third round talks with acquirers and commercial partners.

The test is so now in the end stages of development, as per their presentation video: https://youtu.be/PniHlp5MNJc

"Bring to market as soon as possible"

I suspect at this stage, those sitting on the fence waiting for the next update are going to miss out bigtime. A sale or big partner is coming, much soon than we think. I'd wager early Jan.

Last roll call today for sub 35p all.

The COVID test
Bladder Cancer test
Sepsis test

All in one. This will moon far more than GDR.

Pile in.

$$$$$$$$$$$$$$$$$$$$$$$$$$$$$
Discussions with potential commercial partners and acquirers are now continuing in some depth, with some prospective counter parties having completed a third round of such meetings. The Braveheart board continues to assess what is likely to result in the best outcome for shareholders, whether it is from the potential sale, partnership or retention and full development of the technology.
$$$$$$$$$$$$$$$$$$$$$$$$$$$$$

This looks good for 43-45p near-term again. Should be 50p+ in the New Year given the news that's coming.

https://www.abingdonhealth.com/app/uploads/2021/12/2021-shareholder-circular-and-notice-of-general-meeting.pdf

Some quotes from the 2 Dec Circular:

***

The AbC-19 test is CE marked for professionaluse only and Abingdon Health is actively marketing the test both in the UK and internationally.

In addition, in July 2021, Abingdon Health announced that it had signed an exclusive manufacturing agreement with BioSure (UK) Limited (“BioSure”), a company specialising in the provision of rapid invitro diagnostic testing solutions, for the manufacture of BioSure’s COVID-19 IgG antibody self-test. This test, for which BioSure is the legal manufacturer, has been CE marked specifically for self- testing. The test uses a fraction of a drop of finger-prick blood (2.5uL) with results displayed in 20 minutes.

The Company has made recent progress in relation to two projects involving scale-up and technical transfer to manufacture. Avacta plc’s AffiDX® SARS-CoV-2 antigen lateral flow test is being validated to allow commercial product to be manufactured and released by Abingdon Health. Avacta have indicated that they may require the Company to produce 1-2 million tests per month. The transfer process, which involves scale-up of processes and manufacture of three production-scale manufacturing runs, is progressing well and due for completion in this calendar year. A significant order for post technical transfer production has been received from Avacta.

The Vatic KnowNow™ rapid antigen test, is a UK designed test developed by Vatic Health Limited (“Vatic”), and will be manufactured by Abingdon Health. An initial purchase order has been received for 600,000 tests and Vatic have previously stated that demand could reasonably increase to two million tests per month and ultimately reach 100 million per annum.

***
Then there's the non-covid projects which seem substantial, the big DHSC payment which they seem confident of receiving and more international partners and orders which seem highly likely at this point.

I bet they'll manufacture the GDR tests, just like AVCT too.

100mil mcap + is coming I believe, as a starting point.

I agree. The company has been investing heavily into the production facility, has order agreements being finalised that we know are coming, for example AVCT, from the US and other countries too.

Signs pointing towards considerable revenue growth here and I do think this can multi-bag quickly. More dramatically than GDR given that we're already ahead of them in so many respects.

That's my plan too. :)

Lots of bargain COVID shares!

ABDX has multiple bits of news coming regarding their COVID tests and production. Multiple hints its a formality at this point, just like GDR.

Share price like GDR is at a record low. It'll multi-bag too with the news that's coming.

Not a ramp - a tip. :)

Good luck all.

Would wager the multiple £27k buys and £50k buys, as well as the multiple £100-150k buys yesterday is another ii loading up on the cheap.

Orders for testing kits will be around for years. Once they confirm the AVCT orders soon, this will fly.